Two bodies were recovered from the Manuni Khad in Kangra district while around 15-20 workers stationed at a labour colony near the Indira Priyadarshini Hydroelectric project site were feared swept away following a surge in water level in the Khaniyara Manuni Khad.
The meteorological centre in Shimla issued a 'red' alert on Sunday for very heavy downpour in 10 districts of Himachal Pradesh, while services on the Shimla-Kalka rail line were suspended for hours till the debris and trees fallen on the tracks following overnight rains were removed.
Heavy rains and landslides in Himachal Pradesh have resulted in multiple fatalities and widespread disruption, including road closures and train cancellations.
Six people have died and around 10 people have been injured in heavy rains in Himachal Pradesh that triggered landslides and flash floods in several places in the state, according to official estimates.
Five people were killed and about 50 missing following several incidents of cloudburst in Himachal Pradesh where rains washed away many houses, bridges and roads, officials said on Thursday.
Slapped with Rs 242-crore fine by US authorities for rule violations at Toansa unit, say sources; 2nd such hefty rap in the recent past from US regulators for bending rules.
The PIL , filed by advocate M L Sharma, sought action against Ranbaxy for allegedly supplying substandard and adulterated drugs
All efforts should be on relief, restoration and rehabilitation, Nadda told reporters in Shimla after visiting the rain-affected areas of Poanta in Sirmaur and Shimla town.
Brokerages have cut the company's FY16 earnings estimates between 16% and 29% with target prices too coming down to the Rs 700-800 band
Sun Pharma expects synergy benefits by next fiscal.
Ranbaxy Laboratories on Thursday said it will co-operate fully with any regulator from anywhere in the world wanting to investigate its manufacturing practices.
The Halol facility is important for the company as it accounts for 10 per cent of Sun Pharma's sales.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances